Copyright
©The Author(s) 2017.
World J Gastroenterol. Apr 14, 2017; 23(14): 2470-2482
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2470
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2470
Pathway | Component | Tissue | Outcome | Ref. |
Hh | GLI1 | GBC | ↑ lymph node metastasis | [92,100] |
SHH | CC, GBC | ↑ grade (by trend) | [92,100,101] | |
SMO | GBC | [92] | ||
JAK / STAT | STAT3 | CC, IHC | ↑ tumor size, ↑ metastasis, ↑ vascular invasion, ↓ survival, poor histological differentiation | [102,103] |
mTOR | mTOR | BTC | ↓ survival | [104] |
pmTOR1 | GBC | ↓ survival | [105] | |
NOTCH | NOTCH 1 | EHC | poor histological differentiation, ↓ survival, ↑ tumor grade, ↑ Cyclin E | [86,87] |
NOTCH 2 | EHC | ↓ survival | [86] | |
NOTCH 3 | EHC | ↓ survival, ↑ tumor grade, ↑ Cyclin E | [86,87] | |
NOTCH 4 | EHC | [86] | ||
HES-1 | EHC | ↓ survival | [86] | |
Wnt | β-catenin | CC | ↑ metastasis | [91]2 |
- Citation: Mayr C, Ocker M, Ritter M, Pichler M, Neureiter D, Kiesslich T. Biliary tract cancer stem cells - translational options and challenges. World J Gastroenterol 2017; 23(14): 2470-2482
- URL: https://www.wjgnet.com/1007-9327/full/v23/i14/2470.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i14.2470